Details for Act-HIB vaccine and its components.
Registered for use in infants and children aged 2 months to 5 years.
Monovalent Haemophilus influenzae type b (Hib) vaccine
Lyophilised powder in a monodose vial with a pre-filled diluent syringe.
Each 0.5 mL reconstituted dose contains:
10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to 18–30 µg tetanus protein (PRP-T)
For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.
- polyribosylribitol phosphate
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/act-hib.